BC
NARI

Bridgefront Capital’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Bridgefront Capital’s Portfolio NARI Stock Details NARI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-6,008
Closed -$307K – 891
2024
Q4 		$307K Buy
6,008
+112
+2% +$5.5K 0.1% 353
2024
Q3 		$243K Buy
5,896
+149
+3% +$7.15K 0.09% 395
2024
Q2 		$277K Buy
+5,747
New +$255K 0.12% 317

Other funds holding NARI

SA
SoundView Advisors Olympia, Washington $281M AUM 17.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
TCWM
Total Clarity Wealth Management St. Charles, Illinois $515M AUM 27.37% 1-Year Est. Return
PS
Principal Securities Des Moines, Iowa $6.82B AUM 17.15% 1-Year Est. Return

Bridgefront Capital's NARI Position: Q1 2025 in Review

Bridgefront Capital sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2025, closing a stake of 6,008 shares — an estimated $307K sold.

Bridgefront Capital first reported a position in NARI in Q2 2024 and held it in 3 quarters. The position peaked at $307K in Q4 2024. 4 funds tracked by Wall St. Rank hold NARI as of Q1 2025.

  • Bridgefront Capital reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Bridgefront Capital sold 6,008 Inari Medical, Inc. Common Stock shares in Q1 2025, an estimated $307K.
  • Bridgefront Capital first reported a position in Inari Medical, Inc. Common Stock in Q2 2024 and held it in 3 quarters.
  • Bridgefront Capital's Inari Medical, Inc. Common Stock position peaked at $307K in Q4 2024.
  • 4 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2025.

Based on Bridgefront Capital's 13F filing for Q1 2025, filed 15 May 2025.